Sage Journals: Discover world-class research

Abstract

Despite the widespread use of time-to-event data in precision medicine, existing research has often neglected the presence of the cure fraction, assuming that all individuals will inevitably experience the event of interest. When a cure fraction is present, the cure rate and survival time of uncured patients should be considered in estimating the optimal individualized treatment regimes. In this study, we propose direct methods for estimating the optimal individualized treatment regimes that either maximize the cure rate or mean survival time of uncured patients. Additionally, we propose two optimal individualized treatment regimes that balance the tradeoff between the cure rate and mean survival time of uncured patients based on a constrained estimation framework for a more comprehensive assessment of individualized treatment regimes. This framework allows us to estimate the optimal individualized treatment regime that maximizes the population’s cure rate without significantly compromising the mean survival time of those who remain uncured or maximizes the mean survival time of uncured patients while having the cure rate controlled at a desired level. The exterior-point algorithm is adopted to expedite the resolution of the constrained optimization problem and statistical validity is rigorously established. Furthermore, the advantages of the proposed methods are demonstrated via simulations and analysis of esophageal cancer data.

Keywords

Constraint cure rate exterior-point algorithm mean survival time optimal treatment regime

Get full access to this article

View all access options for this article.

References

Qian

Murphy

. Performance guarantees for individualized treatment rules. Ann Stat 2011; 39: 1180.

Chakraborty

Moodie

. Statistical methods for dynamic treatment regimes. New York: Springer, 2013.

Murphy

. Optimal dynamic treatment regimes. J R Stat Soc Ser B: Stat Methodol 2003; 65: 331–355.

Tian

Alizadeh

Gentles

, et al. A simple method for estimating interactions between a treatment and a large number of covariates. J Am Stat Assoc 2014; 109: 1517–1532.

Guo

Zhou

X-H

. Estimation of optimal individualized treatment rules using a covariate-specific treatment effect curve with high-dimensional covariates. J Am Stat Assoc 2021; 116: 309–321.

Bian

Moodie

EEM

Shortreed

, et al. Variable selection for individualised treatment rules with discrete outcomes. J R Stat Soc Ser C: Appl Stat 2023; 00: 1–16.

Wang

. Model-assisted uniformly honest inference for optimal treatment regimes in high dimension. J Am Stat Assoc 2023; 118: 305–314.

Zhang

Tsiatis

Laber

, et al. A robust method for estimating optimal treatment regimes. Biometrics 2012; 68: 1010–1018.

Zhao

Zeng

Rush

, et al. Estimating individualized treatment rules using outcome weighted learning. J Am Stat Assoc 2012; 107: 1106–1118.

10.

Shi

Song

. Concordance and value information criteria for optimal treatment decision. Ann Stat 2021; 49: 49–75.

11.

Pan

Zhao

Y-Q

. Improved doubly robust estimation in learning optimal individualized treatment rules. J Am Stat Assoc 2021; 116: 283–294.

12.

Chen

Song

Zhang

, et al. On estimating optimal regime for treatment initiation time based on restricted mean residual lifetime. Biometrics 2022; 78: 1377–1389.

13.

Fang

Wang

. Fairness-oriented learning for optimal individualized treatment rules. J Am Stat Assoc 2023; 118: 1733–1746.

14.

Cui

Zhu

Kosorok

. Tree based weighted learning for estimating individualized treatment rules with censored data. Electron J Stat 2017; 11: 3927.

15.

Geng

Zhang

. On optimal treatment regimes selection for mean survival time. Stat Med 2015; 34: 1169–1184.

16.

Liu

, et al. Multi-armed angle-based direct learning for estimating optimal individualized treatment rules with various outcomes. J Am Stat Assoc 2020; 115: 678–691.

17.

Zhao

Y-Q

Zeng

Laber

, et al. Doubly robust learning for estimating individualized treatment with censored data. Biometrika 2015; 102: 151–168.

18.

Jiang

Song

, et al. On estimation of optimal treatment regimes for maximizing t-year survival probability. J R Stat Soc Ser B: Stat Methodol 2017; 79: 1165–1185.

19.

Kang

Zhang

. On estimation of the optimal treatment regime with the additive hazards model. Stat Sin 2018; 28: 1539.

20.

Zhou

Wang

Song

, et al. Transformation-invariant learning of optimal individualized decision rules with time-to-event outcomes. J Am Stat Assoc 2023; 118: 2632–2644.

21.

Cui

Kosorok

Sverdrup

, et al. Estimating heterogeneous treatment effects with right-censored data via causal survival forests. J R Stat Soc Ser B: Stat Methodol 2023; 85: 179–211.

22.

Farewell

. The use of mixture models for the analysis of survival data with long-term survivors. Biometrics 1982; 38: 1041–1046.

23.

Peng

. Nonparametric cure rate estimation with covariates. Canad J Stat 2014; 42: 1–17.

24.

Chen

M-H

Ibrahim

Sinha

. A new Bayesian model for survival data with a surviving fraction. J Am Stat Assoc 1999; 94: 909–919.

25.

Tsodikov

. Semi-parametric models of long-and short-term survival: an application to the analysis of breast cancer survival in Utah by age and stage. Stat Med 2002; 21: 895–920.

26.

Amico

Van Keilegom

. Cure models in survival analysis. Annu Rev Stat Appl 2018; 5: 311–342.

27.

Peng

. Cure models: methods, applications, and implementation. New York: CRC Press, 2021.

28.

Moodie

Stephens

Alam

, et al. A cure-rate model for q-learning: estimating an adaptive immunosuppressant treatment strategy for allogeneic hematopoietic cell transplant patients. Biomet J 2019; 61: 442–453.

29.

Ronellenfitsch

Schwarzbach

Hofheinz

, et al. Perioperative chemo (radio) therapy versus primary surgery for resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagus. Cochr Datab Syst Rev 2013; 2013: CD008107.

30.

van Hagen

Hulshof

Van Lanschot

, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. New Engl J Med 2012; 366: 2074–2084.

31.

Luedtke

van der

Laan

MJ . Optimal individualized treatments in resource-limited settings. Int J Biostat 2016; 12: 283–303.

32.

Qiu

Carone

Sadikova

, et al. Optimal individualized decision rules using instrumental variable methods. J Am Stat Assoc 2021; 116: 174–191.

33.

Rubin

. Bayesian inference for causal effects: the role of randomization. Ann Stat 1978; 6: 34–58.

34.

Hanin

Huang

L-S

. Identifiability of cure models revisited. J Multivar Anal 2014; 130: 261–274.

35.

Patilea

Keilegom

. A general approach for cure models in survival analysis. Ann Stat 2020; 48: 2323–2346.

36.

Jiang

Sun

Peng

. Prediction accuracy for the cure probabilities in mixture cure models. Stat Methods Med Res 2017; 26: 2029–2041.

37.

Dubecz

Gall

Solymosi

, et al. Temporal trends in long-term survival and cure rates in esophageal cancer: a SEER database analysis. J Thorac Oncol 2012; 7: 443–447.

38.

Maller

Zhou

. Estimating the proportion of immunes in a censored sample. Biometrika 1992; 79: 731–739.

39.

Taylor

JMG

. Semi-parametric estimation in failure time mixture models. Biometrics 1995; 51: 899–907.

40.

Robins

Rotnitzky

Zhao

. Estimation of regression coefficients when some regressors are not always observed. J Am Stat Assoc 1994; 89: 846–866.

41.

Liu

Zhan

Lin

, et al. Estimation in optimal treatment regimes based on mean residual lifetimes with right-censored data. Biometr J 2023; 65: e2200340.

42.

Fiacco

McCormick

. Nonlinear programming: sequential unconstrained minimization techniques. Philadelphia: SIAM, 1990.

43.

Joshi

Ramakrishnan

Chandra

, et al. Using sequential unconstrained minimization techniques to simplify SVM solvers. Neurocomputing 2012; 77: 253–260.

44.

Chong

Zak

. An Introduction to Optimization. New Jersey: John Wiley & Sons, 2013.

45.

Doubleday

Zhou

, et al. Risk controlled decision trees and random forests for precision medicine. Stat Med 2022; 41: 719–735.

46.

Stein

von Rahden

Siewert

. Survival after oesophagectomy for cancer of the oesophagus. Langenb Arch Surg 2005; 390: 280–285.

47.

Tao

Wang

. Adaptive contrast weighted learning for multi-stage multi-treatment decision-making. Biometrics 2017; 73: 145–155.

48.

Zhang

Tsiatis

Davidian

, et al. Estimating optimal treatment regimes from a classification perspective. Stat 2012; 1: 103–114.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.58 MB

Optimal treatment regimes in the presence of a cure fraction

Abstract

Keywords

Get full access to this article

References

Supplementary Material